日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Imidazole propionate is a driver and therapeutic target in atherosclerosis.

咪唑丙酸酯是动脉粥样硬化的驱动因素和治疗靶点

Mastrangelo Annalaura, Robles-Vera Iñaki, Mañanes Diego, Galán Miguel, Femenía-Muiña Marcos, Redondo-Urzainqui Ana, Barrero-Rodríguez Rafael, Papaioannou Eleftheria, Amores-Iniesta Joaquín, Devesa Ana, Lobo-González Manuel, Carreras Alba, Beck Katharina R, Ivarsson Sophie, Gummesson Anders, Georgiopoulos Georgios, Rodrigo-Tapias Manuel, Martínez-Cano Sarai, Fernández-López Ivan, Nuñez Vanessa, Ferrarini Alessia, Inohara Naohiro, Stamatelopoulos Kimon, Benguría Alberto, Cibrian Danay, Sánchez-Madrid Francisco, Alonso-Herranz Vanesa, Dopazo Ana, Barbas Coral, Vázquez Jesús, López Juan Antonio, González-Martín Alicia, Nuñez Gabriel, Stellos Konstantinos, Bergström Göran, Bäckhed Fredrik, Fuster Valentín, Ibañez Borja, Sancho David

Women's health: an imAging-based cardiovascular risK-rEdUction Program (WAKE UP) study. Rationale and design

女性健康:一项基于影像老化的心血管风险降低计划(WAKE UP)研究。研究原理和设计

Wasniewski, Samantha; Kfouri Da Silva, Rafaella; Capdeville, Sofía; Rivera Molina, Isabel; Virosta, Elena; Ortiz Cortés, Carolina; Díez-Villanueva, Pablo; Adeba, Antonio; Ruiz Lera, Marta; Muñoz, Lucía; Alonso, David; García, Eva; Echeverría, Ruth; Tarifa, Rocío; Ferrarini, Alessia; Pagán, Josué; Ayala, Jose Luis; Solis, Jorge; Wood, Malissa; Miranda, Blanca; Rodríguez Padial, Luis; Fernández-Friera, Leticia

Decreased serum levels of the inflammaging marker miR-146a are associated with clinical non-response to tocilizumab in COVID-19 patients

COVID-19 患者血清中炎症衰老标志物 miR-146a 水平降低与托珠单抗治疗的临床无反应相关

Sabbatinelli, Jacopo; Giuliani, Angelica; Matacchione, Giulia; Latini, Silvia; Laprovitera, Noemi; Pomponio, Giovanni; Ferrarini, Alessia; Svegliati Baroni, Silvia; Pavani, Marianna; Moretti, Marco; Gabrielli, Armando; Procopio, Antonio Domenico; Ferracin, Manuela; Bonafè, Massimiliano; Olivieri, Fabiola

Metabolomic Analysis of Liver Tissues for Characterization of Hepatocellular Carcinoma.

肝组织代谢组学分析在肝细胞癌表征中的应用

Ferrarini Alessia, Di Poto Cristina, He Shisi, Tu Chao, Varghese Rency S, Kara Balla Abdalla, Jayatilake Meth, Li Zhenzhi, Ghaffari Kian, Fan Ziling, Sherif Zaki A, Kumar Deepak, Kroemer Alexander, Tadesse Mahlet G, Ressom Habtom W

Multi-omic Pathway and Network Analysis to Identify Biomarkers for Hepatocellular Carcinoma

利用多组学通路和网络分析鉴定肝细胞癌的生物标志物

Barefoot, Megan E; Varghese, Rency S; Zhou, Yuan; Poto, Cristina Di; Ferrarini, Alessia; Ressom, Habtom W

Identification of race-associated metabolite biomarkers for hepatocellular carcinoma in patients with liver cirrhosis and hepatitis C virus infection

在患有肝硬化和丙型肝炎病毒感染的患者中,鉴定与种族相关的肝细胞癌代谢物生物标志物

Di Poto, Cristina; He, Shisi; Varghese, Rency S; Zhao, Yi; Ferrarini, Alessia; Su, Shan; Karabala, Abdullah; Redi, Mesfin; Mamo, Hassen; Rangnekar, Amol S; Fishbein, Thomas M; Kroemer, Alexander H; Tadesse, Mahlet G; Roy, Rabindra; Sherif, Zaki A; Kumar, Deepak; Ressom, Habtom W

Topic model-based mass spectrometric data analysis in cancer biomarker discovery studies

基于主题模型的质谱数据分析在癌症生物标志物发现研究中的应用

Wang, Minkun; Tsai, Tsung-Heng; Di Poto, Cristina; Ferrarini, Alessia; Yu, Guoqiang; Ressom, Habtom W

Multi-omic approaches for characterization of hepatocellular carcinoma

多组学方法在肝细胞癌表征中的应用

Ressom, Habtom W; Di Poto, Cristina; Ferrarini, Alessia; Yunli Hu; Nezami Ranjbar, Mohammad R; Ehwang Song; Varghese, Rency S; Minkun Wang; Shiyue Zhou; Rui Zhu; Yiming Zuo; Tadesse, Mahlet G; Mechref, Yehia

Eplerenone attenuated cardiac steatosis, apoptosis and diastolic dysfunction in experimental type-II diabetes

依普利酮可减轻实验性 II 型糖尿病的心脏脂肪变性、细胞凋亡和舒张功能障碍。

Ramírez, Elisa; Klett-Mingo, Mercedes; Ares-Carrasco, Sara; Picatoste, Belén; Ferrarini, Alessia; Rupérez, Francisco J; Caro-Vadillo, Alicia; Barbas, Coral; Egido, Jesús; Tuñón, José; Lorenzo, Óscar